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Abstract
Background: Cardiac Troponin-T (cTnT) is a cardio-specific indicator of myocardial necrosis due to ischemic or
non-ischemic events. Considering the multiple causes of myocardial injury and treatment consequences there is
great clinical need to clarify the underlying reason for cTnT release. We sought to implement acute CMR as a non-
invasive imaging method for differential diagnosis of elevated cTnT in chest-pain unit (CPU) patients with non-
conclusive symptoms and ECG-changes and a low to intermediate probability for coronary artery disease (CAD).
Results: CPU patients (n = 29) who had positive cTnT were scanned at 1.5T with a new step-by-step CMR
algorithm including cine-, perfusion-, T2-, angiography-and late gadolinium enhancement (LGE) imaging. For
comparison patients also underwent echocardiography and coronary angiography if necessary. CMR was
conducted successfully in all patients and detected 93% of cTnT releases of unknown cause, without adverse
hemodynamic or arrhythmic events. Acute myocardial infarction was detected in 11, pulmonary embolism in 6,
myocarditis in 5, renal disease and cardiomyopathy in 2, storage disorder in 1 patient. In 2 patients CMR was
unable to reveal the cause of cTnT elevations. Mean CMR scan-time was 35 ± 8 min. In 4 patients, CMR led to
immediate coronary angiography with correct prediction of the infarct related artery.
Conclusions: We implemented a novel CMR algorithm to show the clinical value and practical feasibility of acute
CMR in a non-conclusive patient cohort with unclear cTnT elevation. Since this pilot study has shown the feasibility
of CMR in CPU patients, further prospective studies are warranted to compare CMR with other imaging modalities.
Background
Cardiac troponin T (cTnT) is well established as pre-
ferred biomarker for detection of myocardial necrosis
due to its absolute cardiospecificity [1]. Numerous clini-
cal trials have established the role of cTnT in patients
with suspected acute coronary syndrome for the diagno-
sis of acute myocardial infarction (AMI) as well as its
power for risk strtification of patients with acute coron-
ary syndromes (ACS) with [2] and without ST-segment
elevation (STEMI/NSTEMI) [3].
Although the detection of cTnT in blood is specific
for myocardial injury, it is not specific as to the cause of
the myocardial damage. cTnT is also elevated in non-
coronary cardiac diseases [4] including acute pulmonary
embolism [5,6] (PE), acute heart failure [4], myocarditis
[7] and toxic injury. If elevated in non-ACS conditions,
cTnT elevations are associated with a high cardiac event
rate, as shown for example in patients with end-stage
renal disease (ESRD) [8].
In all these conditions cTnT elevations are associated
with an adverse prognosis with a subsequent substantial
need to diagnose and treat the underlying cause of
cTnT liberation.
Cardiovascular magnetic resonance (CMR) is a non-
invasive comprehensive imaging technique that simulta-
neously allows assessment of cardiac anatomy, tissue
characterization and functional analysis of right and left
ventricles (RV, LV). Cardiac dimensions, hypertrophy
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easily visualized in breath-hold cine SSFP sequences with
superior image quality [9]. Inflammation [10], myocardial
hypo-perfusion [11] and infarct-related necrosis [12] are
distinctly detectable using T2-edema-or late gadolinium
enhancement (LGE) imaging techniques [13]. Further-
more, gadolinium can be utilized for high resolution pul-
monary and aortic angiographies to exclude pulmonary
embolism [14] or aortic dissection [15].
We sought to implement acute CMR and a novel
step-by-step algorithm as a non-invasive diagnostic ima-
ging method for differential diagnosis of elevated cTnT
in hemo-dynamically stable patients with non-conclusive
symptoms, non-diagnostic ECG, and low to intermediate
probability for CAD [16].
Methods
Patients
Patients with an elevated cTnT (> 0.03 μg/L) had to ful-
fil the following criteria for inclusion: 1. low suspicion
of ACS and 2. a) one potential differential diagnosis due
to clinical symptoms, or b) certain laboratory findings
(c-reactive protein elevation, elevated Wells score [17]).
A low likelihood of ACS was defined as a) lack of typi-
cal angina, b) low-intermediate probability of CAD (≥2
cardiovascular risk factors, absent history of CAD) and
c) normal/non-diagnostic ECG. Patients were consecu-
tively enrolled in our CPU between January and June
2006. Patients with a high likelihood for ACS were
excluded and received standard treatment and diag-
nostic work-up, such as immediate, early or deferred
coronary angiography with or without coronary inter-
vention. AMI was diagnosed using the ESC/AHA/ACC
Federation Task Force redefinition of myocardial
infarction guidelines [18].B r i e f l y ,A M Ir e q u i r e dt h e
detection of a rising or falling pattern of cTnT with at
least one of the following: symptoms of ischemia, new
ST-T changes on ECG, development of Q waves on
ECG, or imaging evidence of new loss of viable myo-
cardium. We excluded asymptomatic patients with
ESRD and a constant level of cTnT in two consecutive
samples obtained after an interval of at least 6 hours.
In ESRD patients, a cTnT-change of ≥20% 6-9 h after
presentation has been recommended to indicate an
acute condition [19]. cTnT was regarded to be with a
recommended diagnostic threshold of 0.03 μg/l. The
study protocol was in accordance with the Declaration
of Helsinki and approved by the local ethical commit-
tee. All patients included in the study gave informed
written consent.
Study protocol
After CPU admission and fulfilment of the CMR inclu-
sion criteria, the study patients were consecutively asked
and included. We excluded patients with severe dys-
pnoea, claustrophobia, implanted pacemaker/defibrilla-
tors or other metal devices. Patients who were admitted
between 7pm and 8am were excluded since they were
admitted outside the operating CMR hours. Patients
were transported to the nearby CMR unit (~40 m dis-
tance) with a specific MRI trolley-system (Philips Phy-
sioTrak, Best, the Netherlands) that provides the
possibility of monitoring blood pressure, heart rate and
blood oxygen saturation. The patients’ medication, if
necessary, was continued during transport and CMR
using MR compatible infusion pumps.
During CMR scanning, one technician (B.H., A.W.),
one doctor (H.S., S.L., D.L.) and one study assistant (M.
M . )w e r ep r e s e n ta n da n a l y s e dt h ei m a g e ss i m u l t a -
neously. After diagnosis was made, CMR was stopped
and the patient re-transported to the CPU.
Before or after CMR an additional echocardiography
exam was accomplished in all patients for verification
and comparison with CMR results. Post CMR, suspected
ACS or non-coronary differential diagnoses were con-
firmed by either coronary angiography or 64-slice CT.
When after CMR and echo the diagnosis was clear,
invasive procedures were not obligatory to minimize
patients’ X-ray exposure.
The eight-step CMR algorithm
CMR was performed on a 1.5 T whole body CMR scan-
ner (Achieva®, Philips Medical Systems, Best, the Neth-
erlands). The pre-specified algorithm for stepwise
evaluation is shown in figure 1. The algorithm could be
followed step-by-step or interrupted at each point to
minimize study scan time for the patient.
After scout and reference scans (Step-1), in Step-2 six
SSFP-cine images with parallel imaging (slice-thickness
= 8 mm; sense-factor = 2) were acquired through the
thoracic aorta with subsequent MR angiography if dis-
section was suspected.
At Step-3, two-chamber and multiple short axis SSFP-
cine images were scanned for wall motion abnormalities
and edema [20] to rule out large AMI. If hypo-or akine-
sia was present with suspicion of edema, breath-hold T2
black-blood imaging (TSE-SPIR; slice-thickness = 8 mm;
Sense-factor = 2.3) and gadolinium three-slice perfusion
(Magnevist, Schering Germany;0.05 mmol/kg-bw) ima-
ging (b-FFE; slice thickness = 8 mm;sense-factor = 2)
were conducted. Ten minutes after additional 0.15
mmol/kg-bw gadolinium, multi-slice breath-hold LGE
imaging (FFE-T1, TR/TE 2.6/0.9 ms, slice-thickness = 5
mm, rec. voxel 2/2/5 mm, sense-factor = 2, TI-time =
200-300 ms) followed to estimate infarct size and iden-
tify the affected coronary territory. CMR results were
discussed with the interventional cardiologist for the
need of catheterization.
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four-chamber SSFP-cine images to exclude wall motion
abnormalities of the RV. If PE was suspected, a non-ECG-
triggered 3D-MR pulmonary angiography (3D-FFE, half-
scan-data acquisition; rec voxel = 0.7/0.7/2 mm;sense-fac-
tor = 2.2) was accomplished using double dose gadolinium.
After 10 minutes, LGE imaging was conducted to
potentially visualize RV myocardial necrosis and pul-
monary thrombi.
After triple-rule-out (Step1-4), in Step-5 T2-weighted
short axes were imaged to rule-out edema in peri-/myo-
carditis followed by LGE imaging (see above) to detect
patho-gnomonic inflammation patterns.
If no inflammation was seen, Step-6 contained multi-
slice short axis perfusion imaging to detect small AMI
and, in case of a perfusion defect, LGE imaging.
Step-7 looked for small PE performing 3D-MR pul-
monary angiography, whereas ten minutes after gadoli-
nium administration Step-8 served as tool for detection
of small AMI or peri-/myocarditis. The time points for
patient transportation, CMR preparation and scan dura-
tion were recorded.
Statistics
Data were expressed as mean ± standard deviation or as
median with inter-quartile range (IQR; 25-75th percen-
tile) if not normally distributed. Differences between
two groups were compared by Student’s t-test or Mann-
Whitney-U-Test for non-parametrical continuous vari-
ables. Continuous variables among more than 2 groups
were compared by one-way ANOVA. Categorical vari-
ables between groups were compared by chi-square test
Figure 1 Eight-step Heidelberg CMR algorithm.
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were regarded statistically significant. All statistical ana-
lyses were carried out using MedCalc 9.4.1.0 (MedCalc
Statistical Software bvba, Belgium).
Results
Study screening and patient characteristics
Between January and July 2006, 1412 cTnT positive
patients were admitted to our CPU. Out of 1,412 eligible
patients during this time, 804 were admitted between
7pm and 8am (outside the operating times) and could
therefore not be included. Of the remaining 608
patients, 110 had a STEMI and received interventional
treatment. Of the now remaining 498 patients, 407
patients were clearly diagnosed with NSTEMI with
either immediate or delayed invasive diagnostic treat-
ments. Out of the rest of 91 patients, 55 showed either
a unequivocal clinical signs of pulmonary embolism,
myocarditis or renal failure without cTnT serum level
changes cTnT-change of ≥20% 6-9 h after presentation.
We were thus left with 36 patients who could poten-
tially be included in this pilot study after careful investi-
gations in the CPU. In seven of these 36 patients CMR
could not be performed due to claustrophobia or metal
implants (4/3 patients). Therefore, 29 patients were
included for the final study. The characteristics of the
study cohort are shown in table 1.
Differential Diagnoses detected by CMR
The CMR protocol was feasible in all 29 cases. During
transportation, CMR preparation and scanning, no
arrhythmias or hemo-dynamic instability were noted. In
our study, the CMR diagnoses were AMI in 11, pulmon-
ary embolism (PE) in 6, peri-/myocarditis in 5, elevated
cTnT due to ESRD in 2, cardiomyopathy (CMP) in two
and storage disease in 1 patient. In two patients, no
diagnosis was found (figure 2). Some clinical CMR
examples are given in figure 3.
AMI patients showed significantly more cardiovascular
risk factors (2.9 ± 0.4, p = 0.04), higher admission cTnT
(1.8 ± 3 ng/ml) and the highest TIMI score (2.6 ± 1.3) of
all groups. CMR detected NSTEMI in nine of eleven cases.
In coronary angiography, significant CAD ( > 50% luminal
obstruction) could be ruled out in one case. Seven cases
showed a single-vessel and three showed a two-vessel dis-
ease. Nine cases received PCI in at least one lesion.
In six patients PE was detected by CMR. Admission
cTnT was significantly lower (0.15 ± 0.14 ng/ml;p =
0.023) compared to the AMI group, but had the highest
Wells score
17 (2.2 ± 2). Since CMR clearly showed PE
in four of six patients, only two patients received non-
invasive CT for diagnosis confirmation. No heart cathe-
terisation was demanded by the attending physician so
that CMR saved invasive procedures in all six cases.
Five significantly younger patients (48 ± 32years;p
< 0.05) with low incidence for cardiovascular risk factors
(1.0 ± 0.1), low Wells (0.3 ± 0.7) but high serum levels of
CRP (102 ± 81 mg/dl) revealed peri-/myocarditis on CMR.
Two patients with ESRD (creatine = 2.6 ± 0.1 mg/dl;
M D R D=3 1±0m l / m i n ) ,k n o w nC A Da n dT - w a v e
inversions with ST-deviations, but new onset of atypical
chest pain, neither showed wall motion abnormality,
edema, perfusion defect nor infarct-typical LGE on
CMR. Therefore in both cases no coronary angiography
was demanded by the attending physician.
Two elderly female patients without any cardiovascular
risk factors, low Wells scores (0.5 ± 0.3) and moderate
cTnT levels (0.28 μg/l ± 0.1) revealed either tachy-
arrhythmia or ST-deviation after psychogenic stress.
CMR showed apical ballooning without T2-edema or
LGE and classified them as Tako-Tsubo cardiomyopathy.
One younger patient with a moderate cTnT level
(0.31 ng/ml), three CAD risk factors, sinus-tachycardia
and T-wave inversions showed a moderately reduced
Table 1 Patient demographics and characteristics
No. of patients 29
Age (yrs) 57 ± 17
Sex f/m-n (%) 9/20 (31/69)
BMI (kg/m
2) 25.6 ± 4.7
RR syst. (mmHg) 133 ± 9
RR diast. (mmHg) 77 ± 7
Heart rate (beats/min) 83 ± 19
Fever >37.5°C 6/29
Cardiovascular risk factors
Diabetes - n (%) 6 (21)
Smoking -n (%) 12 (42)
Hypertension - n (%) 16 (55)
Hyperlipidemia-n (%) 13 (45)
Family history-n (%) 13 (21)
TIMI Score 2.2 ± 1.2
Wells Score 1.0 ± 1.4
Serum parameters
cTnT admission (ng/dl) 0.9 ± 1.9
cTnT max. (ng/dl) 1.5 ± 3.9
Creatinine (mg/dl) 1.2 ± 0.6
GFR (ml/min) 75 ± 29
Leucocytes (/nl) 10.0 ± 4.3
...CRP (mg/dl) 45 ± 59
ECG criteria
Sinus rhythm -n (%) 26 (90)
Tachycardia -n (%) 7 (24)
Left bundle branch block -n (%) 1 (3)
Right bundle branch block -n (%) 1 (3)
S1Q3 type -n (%) 1 (3)
T-inversion -n (%) 13 (45)
ST-deviation -n (%) 7 (24)
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hypertrophy with thickened heart valves. Surprisingly,
LGE imaging showed amyloidosis gadolinium-patterns.
The patient refused myocardial biopsy but coronary
angiography showed an insignificant LAD lesion. The
patient refused any further diagnostics and discharged
himself prematurely.
In two elderly patients with low cardiovascular risk
profile (0.5 ± 0.5), marginally elevated cTnT (0.03 μg/l),
good renal function (1.2 ± 01 mg/dl, 96 ± 42 ml/min),
inconspicuous lab-works, no high grade stenosis on X-
r a yb u tn e wa r r h y t h m i aw i t hT - w a v ei n v e r s i o n s ,t h e
underlying reason for the cTnT elevation could not be
identified.
Comparison of diagnostic methods
In nine of eleven AMI patients, CMR made the correct
diagnosis. In one of them cTnT was only minimally ele-
vated (0.05 ng/ml) with incompliance of breath-hold
commands. The other patient showed tachy-arrhythmia
with consecutive blurred imaging. Both patients were
also misdiagnosed by echocardiography. However, when
compared to CMR, echocardiography missed another
four AMI patients due to not detected wall motion
abnormalities or insufficient acoustic windows. In four
cases, patients with CMR diagnosed NSTEMI received
an earlier coronary angiography procedure due to large
CMR perfusion defects and pronounced LGE patterns.
In all AMI cases, CMR predicted the affected coronary
vessel correctly. Moreover, CMR distinguished all six
patients with PE, whereas echocardiography missed half
of them due to insufficient image quality. Since CMR
showed the exact localisation of the pulmonary thrombi
as well as right ventricular function in at least four of
six patients undoubtedly, coronary angiography was not
conducted.
Similarly, CMR distinguished conclusively all patients
with peri-/myocarditis because of characteristic gadoli-
nium patterns. In only one case with regional wall
motion abnormalities and pericardial effusion, echocar-
diography offered the correct diagnosis. Again, CMR
saved coronary angiography procedures in these
patients. In two patients, where all three methods could
not find a diagnosis, CMR could at least rule out wall
motion abnormalities, perfusion defects, edema or sig-
nificant myocardial necrosis in all 17 AHA segments,
Figure 2 Although clinically in-conclusive the study group
comprised 11 AMI-, 6 PE-, 5 peri-/myocarditis-, 2 ESRD and
CMP-and one amyloidosis patient. In two patients no diagnosis
could be found.
Figure 3 A+B) 63 year-old patient with inferior wall AMI, T2-edema and hypo-kinesia on short- axis SSFP-images (A) and concomitant
LGE (B). C+D) 29 year-old patient with excessively dilated right chambers and systolic dysfunction on SSFP-images (C) revealing thrombi in the
proximal left pulmonary artery (D) on pulmonary angiography. On echocardiography the patient showed only insufficient image quality. E+F) 45
year-old patient with intermitting fever and edema at the LV lateral wall on T2-four chamber images (E) without wall motion abnormalities but
clear patchy, infarct-atypical LGE images confirming the diagnosis of myocarditis (F). G+H) 32 year-old patient with slightly elevated cTnT levels,
moderately reduced ejection fraction (EF = 43%), symmetric myocardial hypertrophy (G) and diffuse LGE patterns (H) suspicious of cardiac
amyloidosis. I+J) 62 year-old woman with signs of mid-ventricular ballooning (I) without edema or LGE (J) was classified as tako-tsubo CMP.
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methods. In the two cases of renal dysfunction, CMR
again could not show any acute pathology, so that deci-
sions could be made not to proceed with coronary
angiography since the coronary status was known from
former exams.
CMR time course for differential diagnoses
In figure 4 seven time bars with average duration of
CMR in the different groups are presented. The overall
time duration was approximately 1 hour. Mean trans-
portation time to the CMR scanner was 2.5 ± 1 min,
preparation time 15 ± 2 min, CMR scan time was
between 24 ± 9 min for PE and 44 ± 1 min for patients
in which no diagnosis could be found. Transportation
back to the CPU after CMR was 11 ± 3 min.
Discussion
For the first time, we show in this prospective pilot
study that CMR is useful for confirmation of ACS, adds
information on infarct localisation and extent, and may
provide a conclusive differential diagnosis in the major-
ity of patients with elevated cTnT concentrations but
equivocal signs or symptoms of ACS. Thus, CMR may
improve the diagnostic work-up, and may be helpful for
patient management. CMR can be completed within 35
minutes, is safe and well tolerated.
CMR for the differential diagnosis of elevated cTnT in
patients with low or intermediate probability of ACS
CTnT is highly sensitive and characterized by absolute tis-
sue specificity for myocardium. As elevated cTnT is not
always due to myocardial infarction, cTnT in patients with
equivocal signs or symptoms for ACS may be caused by
differential diagnoses including myocarditis [13], PE [14]
or ESRD [19]. Accordingly, confirmation of suspected
ACS or accurate differential diagnosis is of paramount
importance to avoid unnecessary invasive procedures and
to customize therapies. Although the diagnosis of ACS
was equivocal in our patients, 30% had cTnT elevation
due to NSTEMI and 9 of 11 cases required subsequent
PCI. And although the Wells score demonstrated low clin-
ical pre-test probability for PE, CMR confirmed pulmon-
ary thromboemboli and right ventricular dysfunction in
another 6 cases. Therefore, our results demonstrate the
usefulness of a comprehensive MR study for differential
diagnosis in selected patients with elevated cTnT but with
equivocal findings and non-conclusive diagnoses.
CMR identified 93% of the diagnoses in this CPU
patient group. The reason for the minute cTnT rises in
two patients (0.03/0.07 ng/l) could not be discovered. In
both patients the diagnostic image quality was consider-
ably reduced due to breath-hold incompliance and
tachy-arrhythmia. In contrast to previous CT CPU-trials
[21], we included also patients with sub-optimal imaging
conditions to apply CMR in a clinically realistic setting.
Another explanation that we could not find a potential
LGE area in the two patients with the slightly elevated
cTnT levels could be the employment of our single
breath-hold multi-slice-LGE MR sequence holding the
disadvantage of a lower image resolution. Therefore,
small-sized LGEs could have been overlooked.
Compared to CMR, echocardiography only detected five
of eleven AMI patients due to small infarct sizes without
wall motion abnormalities. One could argue that perfusion
imaging by echocardiography would increase the sensitiv-
ity, but even high resolution gadolinium multi-slice perfu-
sion CMR did not reveal noticeable defects. The difference
in performance between CMR and echocardiography
becomes even more pronounced in patients with PE and
peri-/myocarditis, which was the underlying reason in
more than 30% of cTnT releases. If PE did not cause RV-
dysfunction, echocardiography failed to clarify diagnoses
in three patients due to insufficient RV image quality,
which is in line with common literature [22]. MR angio-
graphy on the other hand enabled visualization of central
and peripheral pulmonary thrombi using high-resolution
sequences [23]. Also, if peri-myocarditis did not affect wall
motion or cause pericardial effusions [22], echocardiogra-
phy was unable to find the correct diagnosis [24] because
of insufficient inflammatory tissue characterisation.
Feasibility of CMR
All patients were successfully scanned with good image
quality and without claustrophobia, with a mean time
Figure 4 Time bars with average CMR time durations for all
differential diagnoses.
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scans were conducted between the first and second
cTnT measurements (six hours), therefore not causing
prolonged patient CPU-stay. CMR could reliably distin-
guish between hazardous differential diagnoses, which
had substantial influence on further diagnostic or thera-
peutic proceedings. Neither coronary angiography nor
echocardiography combined the comprehensive ability
of highly reproducible functional as well as and tissue
characterisation. Although state-of-the-art CT has
superior image resolution for coronary imaging or
angiographies, it lacks high-resolution functional and
perfusion data so far. Furthermore, inflammatory tissue
characterisation cannot be diagnosed appropriately.
Thirdly, X-ray and iodine contrast agent administration
would have led to a considerable additional radiation
exposure in all AMI cases.
Diagnostic decisions and clinical proceedings after CMR
CMR led to reduced coronary angiography procedures in
thirteen cases (6 PE, 5 peri/myocarditis, 2 ESRD), whereas
in the 2 ESRD patients the physician decided for non-inva-
sive proceeding because of non-pathological CMR findings.
Since CMR predicted all affected coronary AMI territories
correctly, it could lead to reduced X-ray exposure in this
patient cohort. The concept of CMR implies several essen-
tial requirements: 1) short-term clinical access to an CMR-
system with a CPU nearby, 2) safe patient monitoring, 3)
CPR trained CMR staff, 4) experienced CMR readers and
5) immediate CMR interpretation. Recently published
CPU-CMR studies showed a clear clinical benefit in ACS
patients [25]. In conclusion, we implemented the Heidel-
berg CMR-algorithm to show the clinical value in a clini-
cally inconclusive patient cohort showing unclear cTnT
elevations. Since this pilot study has shown the CMR feasi-
bility, further prospective studies comparing CMR with dif-
ferent imaging modalities like CT are warranted.
Limitations
We gave gadolinium in two patients with low GFR (34
ml/min), which requires caution because of the potential
induction by some contrast agents of nephrogenic sys-
temic fibrosis (NSF) [26]. Coronary angiography was not
conducted in all patients for comparison with CMR and
echocardiography. After an unequivocal diagnosis find-
ing, patient management was left at the discretion of the
attending cardiologist.
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